LCG
AMAG

Lisanti Capital Growth’s AMAG Pharmaceuticals AMAG Stock Holding History

Lisanti Capital Growth’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-29,325
Closed -$2.02M – 101
2015
Q2 		$2.02M Sell
29,325
-10,840
-27% -$682K 1.46% 28
2015
Q1 		$2.19M Sell
40,165
-8,905
-18% -$424K 1.25% 30
2014
Q4 		$2.09M Buy
+49,070
New +$1.77M 1.05% 48

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lisanti Capital Growth's AMAG Position: Q3 2015 in Review

Lisanti Capital Growth sold out of AMAG Pharmaceuticals (AMAG) in Q3 2015, closing a stake of 29,325 shares — an estimated $2.02M sold.

Lisanti Capital Growth first reported a position in AMAG in Q4 2014 and held it in 3 quarters. The position peaked at $2.19M in Q1 2015. 210 funds tracked by Wall St. Rank hold AMAG as of Q3 2015.

  • Lisanti Capital Growth reported no remaining AMAG Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Lisanti Capital Growth sold 29,325 AMAG Pharmaceuticals shares in Q3 2015, an estimated $2.02M.
  • Lisanti Capital Growth first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 3 quarters.
  • Lisanti Capital Growth's AMAG Pharmaceuticals position peaked at $2.19M in Q1 2015.
  • 210 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2015.

Based on Lisanti Capital Growth's 13F filing for Q3 2015, filed 22 Oct 2015.